ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase... (1 programs will yield positive results o...)

ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program

Date:8/6/2009

1 programs will yield positive results or that we will conduct additional studies with NTCD. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2009, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
10. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
11. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008

Post Your Comments:

(Date:11/21/2009)... Innovative medical apparel com...rence , San Clemente, Cal...ker of breakthrough medical apparel, today announc... display at Medica 2009, a leading international t...orf, Germany. Medelita inaugurates its men,s colle...

(Date:11/20/2009)..., Pioneering Neurologist Closer to Understandin... 20 Dr. Jeremy Schmahma...ol and neurologist at the Massachusetts General Ho...ted his laboratory,s research on the new field of ...INDlink Foundation. ,, Dr. Schmahmann is an awa...

(Date:11/20/2009)... Senators and Congressmen in Co...Over their Health Care Vote , ...enators and congressmen running for re-election ne...ical guru Charlie Cook, may come to regret voting ... bill, according to a breaking Zogby International...

(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNe...s on a mission to redefine what it means to be "ha...al counselor with a specialty in family counseling... Forest University, Gladding says research shows t...s to sadness and even depression during the holida...

(Date:11/20/2009)... blood pressure readings in children with chronic ...even during doctor,s office visits increasing a c...to research from Johns Hopkins Children,s Center a...pears online in the Journal of American Society of...sure measurements obtained during regular doctor v...

Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2 Health News:Medelita Introduces Men's Lab Coat Collection 3 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2 Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3 Health News:Why Holidays Don't Have To Be 'Happy' 2 Health News:High blood pressure easy to miss in children with kidney disease 2

[0] Medelita Introduces Men's Lab Coat Collection [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill [0] Why Holidays Don't Have To Be 'Happy'[0] High blood pressure easy to miss in children with kidney disease

...s Fully Accrued in Financial Statements, COLORADO...on (Nasdaq: SPNC ) today announced it plans to ap...th Dr. Peter Rentrop in the,U.S. District Court in...ial motions. The preliminary jury award of,legal f...

... revolutionary unobtrusive sensor that collects an...ould boost British sporting success in future. , ... the sensor is unique in two key respects. First, ..., response to shock waves travelling through the b...

...X, Sept. 12 Arizona,s "Not Even Once(R)" Youth,Pl...hase two of the ARIZONA,METH PROJECT mass media yo...rd-hitting television, outdoor and print advertisi...ssroots effort that,captured names and personal co...

...O, Sept. 12 A series of mega events in,Hispanic c...07 Heart Health,Campaign during September, Cholest...event in Chicago will be this Saturday and Sunday,...t the,Health Supersite at 26th and Kostner in the ...

...O, Sept. 12 /PRNewswire-FirstCall/ - Transition Th...SX: TTH, NASDAQ:TTHI) a product-focused,biopharmac...e indications,with large markets, today announced ... release, the,Company achieved the following signi...

...acilities Treated with the Antimicrobial Protectio...ortCoatings(TM), EAST RUTHERFORD, N.J., Sept. 12 ...scoring with the high-tech SportsAide(R) treatment...amily of treatments that inhibit and minimize micr...

Spectranetics to Appeal Decision in Patent Litigation Leading-edge body sensor could help produce sporting champions ARIZONA METH PROJECT Unveils Arizona's Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month Transition Therapeutics Announces Fiscal 2007 Year End Financial Results New Jersey Nets Shoot Down Staph with High-Tech Defense

(Date:11/20/2009)...v. 20 The National Association of ...ed a new initiative in the war on methamphetamine.... multi-state electronic tracking program that enfo...) medicines containing pseudoephedrine in real-tim...is based on a system that was developed and tested...

(Date:11/20/2009).... 20 The Department of ...o members of priority groups that did not have pre...linics are being held statewide on Nov. 20-22. Fri... on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On...p.m. to 8 p.m. ,, Individuals in the recommend...

(Date:11/20/2009)... Reportlinker.com announces that a...talogue. ,, Pipettes & Pipettors - A Globa...ker.com/p0164373/Pipettes--Pipettors---A-Global-Ma...m_medium=pr&utm_campaign=prnewswire ,, Pi...rt of any research laboratory. Large-scale applica...

[0] National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production [0] Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available [0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective

...Phase II Testing Certification with Edifecs CORE T...at are now required in X12 Version 5010 , , BELLE...t it will, together with its partners CAQH and Har... lessons learned from the CORE Phase II Certificat...ed 5010 Rules, in a presentation at the HIMSS09 In...

...ovo Nordisk today announced that the Endocrinologi...ited States Food and Drug Administration (FDA) has... liraglutide, a once-daily human GLP-1 analogue. ...ated to the risk profile of liraglutide. , , ...upported that appropriate evidence of cardiovascul...

Other Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4 Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

...eter with graphic display and IOL power calculatio...ination units include firmware module with SRKII, .... Audible tones increase in frequency the closer y...t is achieved with corneal indentation. Triple ton...

...") is an exceptionally high resolution, versatile ...atic deflection) display. This provides substantia...monitors. Vitreous structures such as posterior hy...umor vascularity and macular edema are routinely d...

...B-scan system which quickly identifies ocular asym...s differ by more than 0.3 mm, a staphyloma or othe...enables quick and easy identification of suspected...nserting shells under the lids. The B5500 B-scan p...

...t a true breakthrough in ophthalmic ultrasound, of...nd diagnostic capability previously unavailable. S...he vitreous. Adjust the gain up to 105db to view v...ard 90db setting - or reduce it to clearly disting...

Medicine Products:

DGH-5100e Combination A-Scan/Pachymeter ISYSTEM-ABD A/B-scan unit B5500 B-scan CineScan A/B-S

ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase...(1 programs will yield positive results o...),Health